PEPG logo

PepGen Inc. Common Stock


PEPG: PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.


Show PEPG Financials

Consumer Interest
SEC Filings

Recent trades of PEPG by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by PEPG's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs Apr. 13, 2010
  • Patent Title: Low-toxicity, long-circulating human interferon-alpha pegylated mutants Feb. 16, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of PEPG in WallStreetBets Daily Discussion


Recent insights relating to PEPG

CNBC Recommendations

Recent picks made for PEPG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PEPG

Corporate Flights

Flights by private jets registered to PEPG